CoChat

A double‐blind, randomized, placebo‐controlled trial of n‐3 versus n‐6 fatty acid‐based lipid infusion in atopic dermatitis

Mayser, P, Mayer, K, Mahloudjian, M, Benzing, S, Kramer, HJ, Schill, WB, Seeger, W, Grimminger, F · 2002 · Journal of Parenteral and Enteral Nutrition
Cited by 80

The DOI matches its Crossref record.

Abstract

BACKGROUND: In the involved epidermis of patients with atopic dermatitis, changes in the metabolism of eicosanoids with increased quantities of the arachidonic acid (AA)‐derived lipoxygenase products have been observed. Free eicosapentaenoic acid (EPA), a fish oil‐derived alternative (n‐3) fatty acid, may compete with AA, resulting in an anti‐inflammatory effect. METHODS: In a 10‐day double‐blind, randomized, placebo‐controlled trial, 22 patients hospitalized for moderate‐to‐severe atopic dermatitis were randomly assigned to receive daily infusions of either a n‐3 fatty acid‐based lipid emulsion (fish oil, 10%; 200 mL/d) or a conventional n‐6‐lipid emulsion (soybean oil, 10%; 200 mL/d). Topical treatment was restricted to emollients. The severity of disease was evaluated daily with scoring of erythema, infiltration, and desquamation and by subjective patient scoring of clinical manifestations. In addition, plasma‐free and total‐bound fatty acids and the composition of membrane fatty acids in blood cells (thrombocytes, granulocytes, and erythrocytes), lipid mediators from isolated neutrophils and platelets, and lymphocyte‐activation parameters were determined. RESULTS: Twenty patients completed the trial. Marked improvement from baseline was seen in both groups. On days 6, 7, 8, and 10, disease severity score‐defined as the sum of all scores‐was more pronounced (p <.05) in the n‐3 group compared with the n‐6 group. Free arachidonic acid in plasma did not change substantially in both groups, whereas plasma‐free EPA, total‐bound EPA, and the membrane EPA/AA ratio markedly increased in response to n‐3‐lipid infusion. In parallel, EPA‐derived lipid mediators appeared, whereas lymphocyte functions were unaffected. In the post‐treatment period (2/4 weeks), relapse was observed in some patients after n‐3 psoralene‐ultraviolet A (PUVA) infusion, whereas there was a marked long‐term improvement in the n‐6 group. CONCLUSIONS: IV n‐3‐fatty acid administration is effective in acutely improving the severity of atopic dermatitis, paralleled by changes in plasma and membrane fatty acid composition and lipid mediator synthesis. The long‐term beneficial effects of IV n‐6 fatty acids should be evaluated further.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0148607102026003151

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 80

Metadata

Authors
Mayser, P., Mayer, K., Mahloudjian, M., Benzing, S., Kramer, H., Schill, W., Seeger, W., & Grimminger, F.
Venue
Journal of Parenteral and Enteral Nutrition
Publisher
Wiley
Published
2002-05
Volume
26
Issue
3
Pages
151-158
ISSN
  • 0148-6071 (ISSN-L)
  • 1941-2444
OpenAlex
W2057760254
Cited by
80
References
0
FWCI
4.03
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A double‐blind, randomized, placebo‐controlled trial of n‐3 versus n‐6 fatty acid‐based lipid infusion in atopic dermatitis. https://app.cochat.ai/papers/10.1177/0148607102026003151
The paper
Mayser, P., Mayer, K., Mahloudjian, M., Benzing, S., Kramer, H., Schill, W., Seeger, W., & Grimminger, F. (2002). A double‐blind, randomized, placebo‐controlled trial of n‐3 versus n‐6 fatty acid‐based lipid infusion in atopic dermatitis. Journal of Parenteral and Enteral Nutrition. https://doi.org/10.1177/0148607102026003151

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.